Genomma Lab Internacional, S.A.B. de C.V. Share Price
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Mexican S.E.
04/09/2026
|
5-day change | 1st Jan Change | ||
| 13.01 MXN | -0.54% |
|
-3.63% | -27.28% |
| Market Cap | 12.69B 752M 647M 609M 556M 1.04B 71.01B 1.04B 7.2B 2.79B 36.43B 2.82B 2.76B 117B | P/E 2026 * |
5.08x | P/E 2027 * | 6.1x |
|---|---|---|---|---|---|
| Enterprise Value | 17.14B 1.02B 874M 823M 752M 1.41B 95.94B 1.41B 9.72B 3.77B 49.22B 3.82B 3.73B 159B | EV / Sales 2026 * |
0.92x | EV / Sales 2027 * | 0.85x |
| Free-Float |
68.95% | Yield 2026 * |
6.41% | Yield 2027 * | 9.47% |
| Markets | Quality | ||
|---|---|---|---|
Mexican S.E.
| LAB B | End-of-day quote | |
OTC Markets
| GNMLF | Delayed | |
|
Deutsche Boerse AG
| GEKA | Delayed |
Last Transcript : Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | -0.54% | ||
| 1 week | -3.63% | ||
| Current month | -1.44% | ||
| 1 month | -7.53% | ||
| 3 months | -11.56% | ||
| 6 months | -26.33% | ||
| Current year | -27.28% |
| 1 week | 12.81 |  | 13.39 |
| 1 month | 12.81 | | 14.31 |
| Current year | 12.81 | | 19.48 |
| 1 year | 12.81 | | 22.84 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 11/04/2023 |
| Director of Finance/CFO | - | 30/11/2015 | |
| Investor Relations Contact | - | 30/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 29/10/1996 | |
Juan Alonso
BRD | Director/Board Member | - | 05/07/2010 |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.54% | -3.63% | -42.41% | -8.83% | 752M | |
| -0.88% | -2.15% | +58.05% | +105.26% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +74.19% | 663B | |
| -1.44% | +0.38% | +20.65% | +76.13% | 453B | |
| -0.52% | +0.62% | +31.43% | +38.32% | 352B | |
| -2.45% | +2.48% | +23.46% | +42.53% | 304B | |
| +1.57% | +1.87% | +1.80% | +12.58% | 252B | |
| -1.55% | +1.11% | +54.15% | +75.59% | 236B | |
| -0.13% | +2.15% | -13.91% | -55.83% | 206B | |
| -0.15% | +3.65% | +31.24% | +103.39% | 187B | |
| Average | -0.73% | +0.99% | +21.87% | +46.33% | 367.91B | |
| Weighted average by Cap. | -0.89% | +0.62% | +37.85% | +67.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.72B 1.11B 955M 899M 821M 1.54B 105B 1.54B 10.62B 4.12B 53.78B 4.17B 4.08B 173B | 19.19B 1.14B 979M 921M 842M 1.57B 107B 1.58B 10.89B 4.22B 55.12B 4.27B 4.18B 178B |
| Net income | 2.19B 130M 112M 105M 96.21M 180M 12.28B 180M 1.24B 483M 6.3B 488M 478M 20.3B | 2.18B 129M 111M 105M 95.47M 179M 12.19B 179M 1.23B 479M 6.25B 485M 474M 20.14B |
| Net Debt | 4.45B 264M 227M 214M 195M 365M 24.93B 366M 2.53B 980M 12.79B 991M 970M 41.2B | 3.56B 211M 182M 171M 156M 292M 19.92B 293M 2.02B 783M 10.22B 792M 775M 32.93B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | MX$13.01 | -0.54% | 6,210,134 |
| 03/09/26 | MX$13.08 | +1.79% | 7,859,188 |
| 02/09/26 | MX$12.85 | -2.36% | 3,449,933 |
| 01/09/26 | MX$13.16 | -0.30% | 3,475,652 |
| 31/08/26 | MX$13.20 | -2.22% | 5,486,178 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
